Bradford J Shafer Insider Trading
Get free email notifications about insider trading for Bradford J Shafer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bradford J Shafer. Bradford J Shafer is a Sr VP, Gen. Counsel, Secretary in Innoviva, Inc. ($THRX) and a EVP, Gen. Counsel, Secretary in Theravance Biopharma, Inc. ($TBPH) and a Sr VP, Gen. Counsel, Secretary in Theravance Biopharma, Inc. ($TBPH).
Over the past year Bradford J Shafer has been an insider in 1 company. The total value of shares held by Bradford J Shafer in this company amounts to $4,345,016.
Bradford J Shafer ranks 6,628 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which Bradford J Shafer is an Insider
Innoviva, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bradford J Shafer: Sr VP, Gen. Counsel, Secretary
Holdings: 412,398 shares
Latest Transaction: Jun 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bradford J Shafer: EVP, Gen. Counsel, Secretary, Sr VP, Gen. Counsel, Secretary
Holdings: 141,994 shares
Current Value: $4,345,016
Latest Transaction: Feb 07 2019
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: SELL
Last 3 months trend: BUY View transactions
Last 3 Months Overview:
Buy: 6x
Sell: 22x
Shares Bought: 279,000
Shares Sold: 230,191
Share Difference: +48,809
Value Difference: +$6,518,112
Latest Insider Trading Transactions of Bradford J Shafer
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 07 2019 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 47,250 | 0 | 189,244 | 142 K to 189.2 K (+33.28 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 65,000 | 0 | 141,994 | 77 K to 142 K (+84.42 %) |
| Nov 21 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 24.79 | 7,006 | 173,679 | 76,994 | 84 K to 77 K (-8.34 %) |
| Aug 29 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 27.71 | 7,119 | 197,282 | 84,000 | 91.1 K to 84 K (-7.81 %) |
| Aug 22 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 26.95 | 7,005 | 188,785 | 91,119 | 98.1 K to 91.1 K (-7.14 %) |
| Aug 09 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 27.85 | 25,355 | 706,182 | 98,124 | 123.5 K to 98.1 K (-20.53 %) |
| Aug 09 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Sell | S | 28.03 | 4,127 | 115,686 | 123,479 | 127.6 K to 123.5 K (-3.23 %) |